What stocks does SBI HEALTHCARE OPPORTUNITIES FUND hold?

SBI HEALTHCARE OPPORTUNITIES FUND holds a portfolio of Indian equity stocks disclosed monthly by SBI Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is managed by SBI Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is SBI HEALTHCARE OPPORTUNITIES FUND portfolio data updated?

Portfolio holdings for SBI HEALTHCARE OPPORTUNITIES FUND are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026

Share: WhatsApp X

Stocks Held

Jun 2026

Equity Holdings

₹4,754.05 Cr

Equity only, excl. debt & cash

Top 5 Weight

33.7%

Moderate

Top 10 Weight

52.2%

Moderate

Changes

0 new · 1 exits

Top Sector

Pharmaceuticals & Biotechnology

64.2% of portfolio

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND exited 1 stock from its portfolio this month. Alkem Laboratories Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 2.11%. Among existing holdings, Cipla Limited saw the biggest increase — now at 3.52% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 5.92%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.2%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

+6.94%

+17.56%

+21.12%

+15.21%

Latest NAV

₹580.29

14 Jul 2026

52W High

₹580.29

At High

52W Low

₹436.68

+33% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+43.8%

2023

+39.7%

2022

-5.0%

2021

+21.5%

2020

+67.7%

2019

+0.5%

2018

-8.8%

2017

+3.3%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.8%

+ve in 66% windows

86.5% / -18.1%

3Y Rolling Avg

17.8% p.a.

+ve in 85% windows

32.2% / -9.6%

5Y Rolling Avg

18.8% p.a.

+ve in 100% windows

34.0% / 6.9%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-13.5%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-22.7%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.0%

Rec: May 2023 (1yr 4mo)

2018 IL&FS

-14.4%

Rec: Apr 2020 (2yr 1mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.60

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.34

Penalises downside volatility only.

Std Deviation (3Y)

12.8%

Lower = more consistent returns.

NAV Chart ₹580.29 14 Jul 2026

Simple Moving Avg: Click to draw · click again to remove

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Chart shows indexed performance (base = 100). Actual NAV: ₹580.29

Sector Shift Industry allocation month-over-month

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.4%	64.9%	▲ +0.6%
Healthcare Services	24.4%	25.9%	▲ +1.5%
Chemicals & Petrochemicals	3.4%	2.7%	▼ -0.7%
Healthcare Equipment & Supplies	2.2%	1.9%	▼ -0.4%
Retailing	0.3%	0.0%	▼ -0.3%

May 2026 → Jun 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.9%	64.2%	▼ -0.7%
Healthcare Services	25.9%	26.1%	▲ +0.2%
Chemicals & Petrochemicals	2.7%	2.7%	● +0.1%
Healthcare Equipment & Supplies	1.9%	2.2%	▲ +0.3%

🔴

Biggest Exit

Alkem Laboratories Limited

2.11% was held · Pharmaceuticals & Biotechnology

↑

Biggest Add

Cipla Limited

+1.68% · now 3.52%

↓

Biggest Trim

Divi's Laboratories Limited

-0.65% · now 5.92%

👋 Other funds also exited

Alkem Laboratories Limited 9 funds

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 → Jun 2026

🔴 1 Exit ↑ 18 Increased ↓ 13 Decreased

#	Stock	Sector	Last Weight (May 2026)
1	Alkem Laboratories Limited ₹96.22 Cr	Pharmaceuticals & Biotechnology	2.11%

#	Stock	Sector	May 2026	Jun 2026	Change
1	Cipla Limited ₹175.85 Cr	Pharmaceuticals & Biotechnology	1.84%	3.52%	+1.68%
2	Max Healthcare Institute Limited ₹254.08 Cr	Healthcare Services	4.76%	5.08%	+0.32%
3	Cohance Lifesciences Limited ₹100.35 Cr	Pharmaceuticals & Biotechnology	1.70%	2.01%	+0.31%
4	Aurobindo Pharma Limited ₹208.39 Cr	Pharmaceuticals & Biotechnology	3.90%	4.17%	+0.27%
5	Poly Medicure Limited ₹107.99 Cr	Healthcare Equipment & Supplies	1.89%	2.16%	+0.27%
6	Acutaas Chemicals Ltd ₹317.36 Cr	Pharmaceuticals & Biotechnology	6.17%	6.35%	+0.18%
7	Krishna Institute Of Medical Sciences Limited ₹108.43 Cr	Healthcare Services	1.99%	2.17%	+0.18%
8	Concord Biotech Limited ₹92.17 Cr	Pharmaceuticals & Biotechnology	1.66%	1.84%	+0.18%
9	Sun Pharmaceutical Industries Limited ₹558.75 Cr	Pharmaceuticals & Biotechnology	11.03%	11.18%	+0.15%
10	Dr. Lal Path Labs Limited ₹49.39 Cr	Healthcare Services	0.84%	0.99%	+0.15%
11	Ajanta Pharma Limited ₹102.68 Cr	Pharmaceuticals & Biotechnology	1.92%	2.05%	+0.13%
12	Sudeep Pharma Limited ₹115.40 Cr	Pharmaceuticals & Biotechnology	2.21%	2.31%	+0.10%
13	Aether Industries Limited ₹135.91 Cr	Chemicals & Petrochemicals	2.65%	2.72%	+0.07%
14	Laurus Labs Limited ₹182.09 Cr	Pharmaceuticals & Biotechnology	3.58%	3.64%	+0.06%
15	Gland Pharma Limited ₹149.70 Cr	Pharmaceuticals & Biotechnology	2.96%	3.00%	+0.04%
16	Gufic Biosciences Ltd. ₹20.35 Cr	Pharmaceuticals & Biotechnology	0.37%	0.41%	+0.04%
17	Nephrocare Health Services Ltd ₹54.19 Cr	Healthcare Services	1.05%	1.08%	+0.03%
18	Global Health Limited ₹73.57 Cr	Healthcare Services	1.46%	1.47%	+0.01%

#	Stock	Sector	May 2026	Jun 2026	Change
1	Divi's Laboratories Limited ₹296.06 Cr	Pharmaceuticals & Biotechnology	6.57%	5.92%	-0.65%
2	Biocon Limited ₹156.86 Cr	Pharmaceuticals & Biotechnology	3.52%	3.14%	-0.38%
3	Abbott India Limited ₹61.06 Cr	Pharmaceuticals & Biotechnology	1.47%	1.22%	-0.25%
4	Fortis Healthcare Limited ₹143.54 Cr	Healthcare Services	3.05%	2.87%	-0.18%
5	Apollo Hospitals Enterprise Limited ₹260.46 Cr	Healthcare Services	5.37%	5.21%	-0.16%
6	Anthem Biosciences Limited ₹141.78 Cr	Pharmaceuticals & Biotechnology	3.00%	2.84%	-0.16%
7	Torrent Pharmaceuticals Limited ₹166.32 Cr	Pharmaceuticals & Biotechnology	3.48%	3.33%	-0.15%
8	Sai Life Sciences Limited ₹123.43 Cr	Pharmaceuticals & Biotechnology	2.54%	2.47%	-0.07%
9	Aster DM Healthcare Limited ₹188.27 Cr	Healthcare Services	3.83%	3.77%	-0.06%
10	Mankind Pharma Limited ₹142.55 Cr	Pharmaceuticals & Biotechnology	2.91%	2.85%	-0.06%
11	Jupiter Life Line Hospitals Ltd ₹127.88 Cr	Healthcare Services	2.62%	2.56%	-0.06%
12	Rainbow Childrens Medicare Limited ₹42.43 Cr	Healthcare Services	0.91%	0.85%	-0.06%
13	Lupin Limited ₹96.76 Cr	Pharmaceuticals & Biotechnology	1.99%	1.94%	-0.05%

What Stocks Does This Fund Hold?

31 stocks — Jun 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹558.75 Cr	Pharmaceuticals & Biotechnology	11.18%
2	Acutaas Chemicals Ltd ₹317.36 Cr	Pharmaceuticals & Biotechnology	6.35%
3	Divi's Laboratories Limited ₹296.06 Cr	Pharmaceuticals & Biotechnology	5.92%
4	Apollo Hospitals Enterprise Limited ₹260.46 Cr	Healthcare Services	5.21%
5	Max Healthcare Institute Limited ₹254.08 Cr	Healthcare Services	5.08%
6	Aurobindo Pharma Limited ₹208.39 Cr	Pharmaceuticals & Biotechnology	4.17%
7	Aster DM Healthcare Limited ₹188.27 Cr	Healthcare Services	3.77%
8	Laurus Labs Limited ₹182.09 Cr	Pharmaceuticals & Biotechnology	3.64%
9	Cipla Limited ₹175.85 Cr	Pharmaceuticals & Biotechnology	3.52%
10	Torrent Pharmaceuticals Limited ₹166.32 Cr	Pharmaceuticals & Biotechnology	3.33%
11	Biocon Limited ₹156.86 Cr	Pharmaceuticals & Biotechnology	3.14%
12	Gland Pharma Limited ₹149.70 Cr	Pharmaceuticals & Biotechnology	3.00%
13	Fortis Healthcare Limited ₹143.54 Cr	Healthcare Services	2.87%
14	Mankind Pharma Limited ₹142.55 Cr	Pharmaceuticals & Biotechnology	2.85%
15	Anthem Biosciences Limited ₹141.78 Cr	Pharmaceuticals & Biotechnology	2.84%
16	Aether Industries Limited ₹135.91 Cr	Chemicals & Petrochemicals	2.72%
17	Jupiter Life Line Hospitals Ltd ₹127.88 Cr	Healthcare Services	2.56%
18	Sai Life Sciences Limited ₹123.43 Cr	Pharmaceuticals & Biotechnology	2.47%
19	Sudeep Pharma Limited ₹115.40 Cr	Pharmaceuticals & Biotechnology	2.31%
20	Krishna Institute Of Medical Sciences Limited ₹108.43 Cr	Healthcare Services	2.17%
21	Poly Medicure Limited ₹107.99 Cr	Healthcare Equipment & Supplies	2.16%
22	Ajanta Pharma Limited ₹102.68 Cr	Pharmaceuticals & Biotechnology	2.05%
23	Cohance Lifesciences Limited ₹100.35 Cr	Pharmaceuticals & Biotechnology	2.01%
24	Lupin Limited ₹96.76 Cr	Pharmaceuticals & Biotechnology	1.94%
25	Concord Biotech Limited ₹92.17 Cr	Pharmaceuticals & Biotechnology	1.84%
26	Global Health Limited ₹73.57 Cr	Healthcare Services	1.47%
27	Abbott India Limited ₹61.06 Cr	Pharmaceuticals & Biotechnology	1.22%
28	Nephrocare Health Services Ltd ₹54.19 Cr	Healthcare Services	1.08%
29	Dr. Lal Path Labs Limited ₹49.39 Cr	Healthcare Services	0.99%
30	Rainbow Childrens Medicare Limited ₹42.43 Cr	Healthcare Services	0.85%
31	Gufic Biosciences Ltd. ₹20.35 Cr	Pharmaceuticals & Biotechnology	0.41%